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M osq u i to - bo rne  pa tho g e n s 
are among the most important 
sources of human disease that 
cause morbid i t y and mor ta l -
ity worldwide. They include the 
viruses responsible for deadly out-
breaks of yellow fever, Rift Valley 
fever, eastern equine encepha-
litis, Japanese encephalitis and 
dengue, and an assortment of 
other serious illnesses caused by 
the etiological agents of West 
Nile fever, St Louis encephalitis, 
Murray Valley encephalitis, Ven-
ezuelan equine encephalitis and 
chikungunya disease. Dengue 
viruses, of which there are 4 se-
rot ypes, cause an est imated 
50-100 million new illnesses each 
year (and 25,000 deaths) while 
the latest chikungunya epidemic 
has lasted longer, affected more 
people, and occurred over a 
wider geographic area than any 
previous outbreak of the disease. 
Yellow fever outbreaks continue 
to occur sporadically in South 
America and Africa when either 
vaccination or vector control are 
inadequate. These outbreaks 
have been controlled by creat-
ing barrier zones of vaccinated 
people and by increasing the 
intensity of vector control. The 
threat of devastating outbreaks 
of yellow fever remains, as illus-
trated by continuing quarantine 
and vaccination requirements 
for international travel. The most 
devastating of all mosquito-borne 
diseases is malaria, which kills an 
estimated 1 million people annu-
ally, while infecting another 500 
million. Although public health ef-
forts have been able to reduce or 
eliminate vector-borne pathogens 
in many situations, some parts of 
the world have actually suffered 
increases dur ing the past  30 
years. A number of agencies have 
responded to this problem with 
much increased levels of atten-
tion: World Health Organization, 
Bill and Melinda Gates Founda-
tion, President’s Malaria Initiative, 
Institute Pasteur, US Centers for 
Disease Control and Prevention, 
and US Nat iona l  Ins t i tu tes  of 
Health. However, morbidity and 
mortality due to mosquito-borne 
diseases is increasing.
Today, mosquito wars are being 
fought around the globe and on 
many fronts. Insecticide-treated 
bed nets are mass-produced 
and distributed to the hardest-
hit malarious regions in Africa, 
India and southern Asia. Vaccines 
have been developed to protect 
humans and domestic animals 
against Yellow fever, Japanese 
encephalitis, Rift Valley fever and 
eastern equine encephalitis, with 
intensive ongoing research target-
ing dengue, West Nile virus, and 
malaria vaccine development. 
New skin and clothing repellents 
for personal protection against 
all biting insects are being de-
veloped, and insecticide and 
related application technology 
development is in full swing. Of 
these, the key component for 
protecting humans from mos-
quito-borne illness is the use of 
effective insecticides that quickly 
Figure 1: Twenty-four-well plate bioassays used to expose first instar Aedes 
aegypti larvae to candidate chemical compounds for insecticide discovery.  
Five larvae are added to each well and observed for mortality after 24 hours.
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kill millions of mosquitoes before 
they can pass their pathogens to 
sicken or kil l humans. Mosquito 
adulticides and larvicides are a 
key component of our assault, 
along with indoor residual spray-
ing and insecticide-treated bed 
nets.
Unfor tunately, mosquitoes are 
fighting back somewhat success-
fully by developing resistance to 
currently used mosquito adul-
t ic ides. To date, at least  100 
species of pathogen-carry ing 
mosquitoes have overcome the 
effects of today’s limited arsenal 
of adulticides. We now have only 
2 chemical classes of adulticides 
ava i lab le fo r  adu l t  mosqu i to 
control: organophosphates (OPs) 
and pyrethroids. Malathion is one 
of our oldest organophosphate 
adulticides and the workhorse of 
this class. It was developed in the 
early 1950s for agricultural pest 
control and has been used ex-
tensively around the world as a 
mosquito adulticide since 1953. 
It is a cholinesterase inhibitor that 
impairs nerve cell transmission. 
Resistant mosquitoes have at least 
3 biochemical processes for de-
toxifying this class of insecticide. 
Pyrethroid insecticides were de-
veloped in the 1970s as analogs 
of pyrethrum, a natural product 
of chrysanthemum flowers, known 
for its insecticidal properties for 
hundreds of years. Pyrethroids 
provide rapid knockdown of mos-
quitoes by binding to sodium 
channels on nerve cells and sub-
sequently depolarizing them to 
stop neural transmission. Resistant 
mosquitoes are now capable 
of detoxifying pyrethroids by the 
above 3 biochemical processes 
and target cell insensitivity. Lar-
vicides offer more target sites for 
killing immature mosquitoes, but 
increased tolerance or resistance 
has also been reported among 
different larvicide classes includ-
ing the stomach poison Bacillus 
sphaericus, insect growth regulator 
(methoprene), and a commonly 
used OP (temephos) among some 
mosquito species.
With only 2 adulticide classes left 
to combat an increasingly resis-
tant adult mosquito population 
and the pressing need for novel 
larv icides with new modes of 
action, a call has been initiated 
by the United States Department 
of  Defense (DoD) and publ ic 
health agencies to develop new 
classes of insecticides that are 
af fordable and ef f icacious in 
killing mosquitoes, especially re-
sistant ones. At the United States 
Department of Agriculture (USDA), 
several research units within the 
Agr icultural Research Serv ice 
(ARS) are actively involved in dis-
covering and developing novel 
insecticides. These units include 
the Mosquito and Fly Research 
Unit (MFRU) at the Center for Medi-
cal, Agricultural and Veterinary 
Entomology (CMAVE) located at 
Gainesville, Florida; the Invasive 
Insect Biocontrol and Behavior 
Laboratory (IIBBL) located at Belts-
ville, Maryland; and the Natural 
Products Utilization Research Unit 
(NPURU) located at Oxford, Mis-
sissippi. Funding for much of this 
research is provided by the DoD’s 
Deployed War-fighter Protection 
(DWFP) Research Program, which 
seeks to develop insecticides with 
new modes of action for both 
military and civilian use. Discussed 
below are the insecticide research 
goals of these ARS units and the 
impressive results from their insec-
ticide discovery programs.
Scientists at the MFRU are using 
high throughput larval screening 
techniques to evaluate thou-
sands of candidate chemical 
compounds provided from in-
dustrial collaborators’ chemical 
libraries. This bioassay technique 
exposes mosquito larvae, usually 
the yellow fever mosquito Aedes 
aegypti, to a large array of candi-
date compounds. Five first instar 
larvae (24 hours old) are added 
to each well of a 24-well plate 
in de-ionized water (950 ml) to 
which larval diet (40 ml), DMSO 
(dimethyl sulfoxide, a substance 
used to stabilize candidate chem-
ical concentration), and the test 
chemical itself are added; see 
Figure 1. Larval mortality is scored 
after 24 hour post exposure. Later, 
the most active compounds are 
tested under a wide range of con-
centrations to determine the lethal 
dose necessary to kill 50 and 90% 
of mosquito larvae. Hundreds 
of chemicals can be screened 
weekly using this system.
Following positive hits from the 
Figure 2: A repeating dispenser used 
for applying minute amounts of 
candidate insecticides to the thorax 
of adult mosquitoes. Mosquitoes are 
immobilized on a chill table.
Figure 3: Dosed adult mosquitoes 
are held for 24 hours to determine 
insecticidal activity.
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larval assay described above, 
candidate compounds are then 
tested on adult mosquitoes to 
determine if they will make good 
adult icides. Three to five day-
old adult female Ae aegypti are 
anesthetized for 30 seconds with 
carbon dioxide and placed on 
a 4°C chill table. A 0.5µl droplet 
of pesticide diluted in acetone is 
then applied to the dorsal thorax 
using a repeating dispenser; see 
Figure 2. After topical treatment, 
mosquitoes are kept in plastic 
cups and supplied with 10% su-
crose solution for 24 hours before 
mortality is scored; see Figure 3. 
All chemicals are subjected to a 
primary screen at a concentration 
of 200 ppm. Active compounds 
f rom the p r imar y  screen a re 
subjected to secondary and/or 
tertiary screening at 20 ppm, 2 
ppm, and 0.2 ppm to determine 
lethal dose 50 and 90 percentiles; 
see Figure 4. Permethrin is used as 
the positive control to measure rel-
ative toxicity and acetone is used 
as a negative control to insure 
that mosquito death is due to the 
compound and not environmen-
tal circumstances. The strategy is 
to pass successful adulticides to 
industrial collaborators for registra-
tion, production, and marketing 
as mosquito control insecticides. 
An additional inducement for in-
dustrial production and marketing 
is the involvement of IR-4 (Inter-
regional Research Project Number 
4) ,  a  USDA sponso red ent i t y 
that facil i tates the registration 
of minor-use pesticides. Military 
entomologists can then assign 
national stock numbers to these 
products through the AFPMB’s pes-
ticide committee for inclusion into 
military stock systems.
To date, MFRU scientists have ex-
amined over 2,000 compounds. 
Of these, over 200 showed high 
activity as a mosquito larvicide, 
of which 28 show high adulticidal 
activity. MFRU chemists are also 
collaborating with chemists at 
insecticides (ie, fipronil, spinosad, 
and imidacloprid) show good 
larvicidal and adulticidal activity, 
compared with that of perme-
thrin. DWFP is now seeking product 
development with pesticide man-
ufacturers through the USDA’s IR-4 
process to provide rapid and in-
expensive registration of proven 
insecticides for new insect pests. 
For example, fipronil is the active 
ingredient in Maxforce® FC Roach 
Killer Bait Gel, a common cock-
roach control product used by 
pest control professionals in urban 
environments. Under the IR-4 pro-
cess, mosquitoes are added as 
a target pest and industry then 
develops a product for use in the 
mosquito control market.
Figure 4: Dr Julia Pridgeon, CMAVE toxicologist, preparing candidate
compounds for screening against Aedes aegypti larvae.
the University of Florida to exam-
ine the USDA historical archives 
of insecticide data by quantita-
tive structure-activity relationship 
(QSAR) modeling to predict and 
synthesize new insecticides. This 
approach was used successfully 
to predict and synthesize effica-
cious repellents. Another source 
from which larvicides and adulti-
cides can be developed is from 
existing insecticides already reg-
istered for use against other pests, 
such as the bioactive ingredients 
found in products registered to 
cont ro l  other  insect pests.  In 
early 2009, 19 registered insec-
ticides with different modes of 
action were tested against mos-
quito larvae and adults. Results 
indicated that 3 relatively new 
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The Invasive Insect Biocontrol and 
Behavior Laboratory (IIBBL) seeks 
to develop insecticides from nat-
urally-produced plant toxins. The 
goal of the IIBBL, funded by the 
DWFP, is to discover and develop 
publ ic health pest icides and 
repellents for control of disease 
vectors,  a key component of 
ARS’s National Program 104 and 
the DWFP Program.
Development of new toxicants 
that  p rov ide novel  modes of 
action or that have other proper-
ties desirable for efficacy, safety, 
and commercialization is based 
on molecules with high vapor 
pressure. When novel toxicants are 
developed, they are less suscep-
tible to enzymatic detoxification 
by insects and can be developed 
as new, fast-acting insecticides, 
whi le insecticides with current 
agricultural registrations can be 
adapted for use against blood-
sucking arthropods.
The key thrust of IIBBL’s approach 
involves QSAR-based modeling of
fast-acting pyrethroid insecticides 
to predict and synthesize novel
compounds of a similar structure 
based on their known enzymatic
Figure 5: Comparison of mosquitoes surviving after 14 minute exposure to a permethrin Fire-Resistant Army Combat 
Uniform (FRACU) sleeve (top) and after 4 minute exposure to a FRACU sleeve treated with a fast-acting insecticide.
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detoxif ication mechanisms in 
disease-carry ing insects. New 
classes of compounds with opti-
mized physiochemical spectrums 
will be then explored to develop a 
second generation of fast-acting 
insecticides. Some of these new 
compounds have the poten-
tial to be used on or in clothing, 
such as in collaborative research 
with MFRU scientists to find faster 
acting insecticides for use with 
mil itary uniforms; see Figure 5. 
Simultaneously, IIBBL is evaluating 
pesticides with current agricul-
tural registrations for their ability 
to control medically-important 
ar thropods. Classes of candi-
date compounds obtained from 
existing chemical l ibraries and 
commercial sources are being 
screened for bioactivity via high 
throughput bioassays against a 
laboratory strain of Ae aegypti. 
Promising compounds are evalu-
ated against additional taxa of 
mosquitoes and other blood-
sucking arthropods including sand 
flies, ticks, and bed bugs, using a 
variety of laboratory and field bio-
assays. A key feature of this thrust 
is to evaluate laboratory toxicity 
in disease vectors to at least 96 
hours post-exposure, since short-
ening the life span of a disease 
vector could possibly break the 
cycle of transmission and thereby 
be of great utility in vector control 
programs. Additionally, IIBBL sci-
entists test, evaluate, and develop 
products for control on food hosts 
(vertebrate hosts such as cattle) 
and resting and breeding sites 
(residual and ovicidal treatments, 
respectively).
Research at the Natural Products 
Utilization Research Unit (NPURU) 
is concentrated in discovering 
natural products with insecticidal 
qualities from native plants. Em-
phas i s  i s  in  f ind ing mosqu i to 
adulticides, larvicides and repel-
lents. NPURU scientists investigate 
both plant compounds and de-
rivatives (modification of these 
compounds) in hopes of “en-
hancing” the strength of naturally 
active repellents and insecticides. 
Under the DWFP program, NPURU 
efforts have resulted in several 
potent larvicides and a repellent 
that is three times longer lasting 
and more potent than DEET.
NPURU is currently investigating 
terpenoid compounds common 
to  Amer ican  and Japanese 
Beautyberry (Callicarpa ameri-
cana L and C japonica Thunb, 
respectively) for the repellency 
activity of callicarpenal and in-
termedeol, determined by NPURU 
scientists to be the responsible 
agents. Callicarpenal may well 
serve as a possible substitute for 
DEET, as ongoing tests with mos-
quitoes and ticks indicate that it is 
as effective as DEET and may be 
better tolerated by DEET-sensitive 
individuals.
The discovery and development of 
novel compounds that kill mosqui-
toes is a long-term and expensive 
endeavor, with final registration 
dependent upon the successful 
completion of a large battery of 
EPA-mandated tests. This testing 
ensures that new compounds are 
not only effective against mosqui-
toes, but that they are safe when 
applied to aquatic habitats or 
in the air and produce minimal 
adverse risk to human, animal, 
and plant health. Although the 
DoD-USDA ARS insecticide devel-
opment program is only five years 
old, results obtained thus far indi-
cate that several compounds with 
new modes of action have shown 
promise for development into 
future public health mosquito con-
trol products. On the horizon are 
new products with unique modes 
of action that will aid mosquito 
abatement and public health 
programs to control both larval 
and adult mosquitoes, especially 
those tolerant or resistant to older 
insecticides routinely used over the 
past 50 years.
